Evidence map›Paper›PMID 35695900›Full record

ReviewThe Journal of membrane biology2022

Evolutionary Conservation, Variability, and Adaptation of Type III Secretion Systems.

Alejandro P Heuck, Marco A Brovedan

Abstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of membrane biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Beyond Antibiotics: What the Future Holds.Antibiotics (Basel, Switzerland) · 2024
    Review
  3. Review
  4. International journal of molecular sciences · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alejandro P HeuckDepartment of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA, 01003, USA. heuck@umass.edu.
Marco A BrovedanDepartment of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA, 01003, USA.
University of Massachusetts Amherst · US

Funding

Inhibitors of T3SS translocon assembly to combat multi-drug resistant P. aeruginosaR41AI149922 · NIAID · MICROBIOTIX, INC · PI HEUCK, ALEJANDRO PABLO, OPPERMAN, TIMOTHY J. · 2020 to 2021
$599k
NIAID NIH HHS R41 AI149922
6 · The paper itself

Abstract

Type III secretion (T3S) systems are complex bacterial structures used by many pathogens to inject proteins directly into the cytosol of the host cell. These secretion machines evolved from the bacterial flagella and they have been grouped into families by phylogenetic analysis. The T3S system is composed of more than 20 proteins grouped into five complexes: the cytosolic platform, the export apparatus, the basal body, the needle, and the translocon complex. While the proteins located inside the bacterium are conserved, those exposed to the external media present high variability among families. This suggests that the T3S systems have adapted to interact with different cells or tissues in the host, and/or have been subjected to the evolutionary pressure of the host immune defenses. Such adaptation led to changes in the sequence of the T3S needle tip and translocon suggesting differences in the mechanism of assembly and structure of this complex.

Indexed as

Bacterial ProteinsType III Secretion SystemsHumansPhylogenyProtein TransportBacterial ProteinsType III Secretion SystemsPore-forming proteinProtein secretionTransloconTransmembrane proteinType-III-Secretion

Identifiers

PMID35695900
OpenAlexW4282562521

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.